Global Heme Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global Heme Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Heme is also known as heme, and its chemical name is ferrous protoporphyrin. It is the prosthetic group of hemoglobin, which is composed of protoporphyrin and ferrous atoms, and heme is a derivative of iron-containing porphyrin.

Market Overview:

The latest research study on the global Heme market finds that the global Heme market reached a value of USD 39.21 million in 2023. It’s expected that the market will achieve USD 103.54 million by 2029, exhibiting a CAGR of 17.57% during the forecast period.

The quality of heme health care products varies

Although the health care product market at the present stage is becoming richer in variety and more diverse in form, it is still in the stage of extensive development and faces disadvantages such as incomplete qualifications, unclear efficacy, and no guarantee of safety. There are some counterfeit and shoddy products on the market that over-promote their efficacy, deceive consumers, and even fail to obtain relevant safety production qualifications. Various reasons cause consumers to have many doubts when choosing. There are a variety of immunomodulatory products on the market, which are often mixed. We should be wary of those products with low technical threshold, no relevant production and R&D qualifications, and no guarantee of efficacy and safety. Therefore, products approved by authoritative organizations and developed by professional institutions are more trustworthy.

There are high capital barriers in the heme industry

The heme industry is a high-tech, high-risk, and high-input industry. In recent years, scientists have discovered that heme can be used to treat nervous system diseases, such as Alzheimer's disease, Parkinson's disease, etc. When new drugs are developed from research and development, clinical trials, trial production to final product market development and product promotion, Each link needs to invest a lot of capital, technology and other resources, and there are also high requirements for the comprehensive quality of R&D personnel such as technical level and experience accumulation; at the same time, the production of drugs also requires a lot of special equipment. expensive. As the development of China's pharmaceutical industry becomes increasingly standardized, the pharmaceutical industry has developed into a technology-intensive and capital-intensive industry. Enterprises entering the pharmaceutical industry need to have advanced technology and strong financial strength.

Region Overview:

Asia Pacific had the highest growth rate of all regions.
In 2022, the share of the Heme market inAsia Pacific stood at 43.06%.

Company Overview:

Wayne Bio is one of the major players in the heme market with a 38.92% share in 2023.

Xiangyang Wein Biotechnology Co., Ltd. was established in 2018 with a registered capital of 50 million yuan. The production base is located in the Economic Development Zone of Zaoyang City, Hubei Province, covering an area of ​​152 acres.

Maikang Biotechnology is a biotechnology company specializing in the technology development, production, marketing and services of biopharmaceuticals, animal nutrition, biological health foods and other products. The company's research and development focuses on medicines, cosmetics, health products and other products, food and With diversified products supplemented by feed protein sources and a series of related peptide products, we have established extensive scientific research partnerships and sales networks.

Maikang Biotechnology is committed to the research and development of biological products based on animals and plants. Currently, it has developed soybean superoxide dismutase (SOD), heme iron peptide, heme, thrombin, bilirubin, edible Grade serum protein powder and other comprehensive products. During the same period, it was also committed to the research and development of albumin peptides and other projects, and achieved certain results.

Facing domestic and foreign markets, Maikang insists on being technology-oriented, constantly innovating, and quickly, extensively and completely providing advanced, high-quality and practical products, technologies and services to biomedical industry, bio-food industry, agriculture and animal husbandry. As a professional marketing company in the bio-food industry and agriculture and animal husbandry, Maikang fully promotes the implementation of GSP, works with all peers to compete fairly, and collaborates in a friendly manner to jointly create a good industry standard and business atmosphere, and strives to contribute to the global biological products industry. Make the greatest contribution to the development of agriculture and animal husbandry

Segmentation Overview:

The Pig source segment by type showed a value growth of 0.03% in 2022.

Among different product types, Pig source segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Medical insurance segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Heme market covered in Chapter 3:

Gansu Yangtaihe Biotechnology Co., Ltd.
Zhejiang Maikang Biological Engineering
Wayne Bio
Sichuan Deboer Pharmaceutical
Hubei Dibai Chemicals

In Chapter 4 and Chapter 14.2, on the basis of types, the Heme market from 2019 to 2030 is primarily split into:

pig source
Niu Yuan
other

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Heme market from 2019 to 2030 covers:

food
medical insurance
feed
other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)